Anas, Maira A.
HRN: 24-02-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2023
AMPICILLIN 1GM (VIAL)
11/02/2023
11/08/2023
IVT
2gm
Now Then Q6
Thickly MSAF
Checking Final Appropriateness
Indication: ProphylaxisEmpirical De-escalation Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes